Tech Company Financing Transactions

BioRelix Funding Round

On 9/6/2011, BioRelix landed $3.6 million in investment from private investors.

Transaction Overview

Company Name
Announced On
9/6/2011
Transaction Type
Venture Equity
Amount
$3,644,085
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Winchester Ave.
New Haven, CT 06511
USA
Email Address
Overview
BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.
Profile
BioRelix LinkedIn Company Profile
Social Media
BioRelix Company Twitter Account
Company News
BioRelix News
Facebook
BioRelix on Facebook
YouTube
BioRelix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joel Marcus
  Joel Marcus LinkedIn Profile  Joel Marcus Twitter Account  Joel Marcus News  Joel Marcus on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/6/2011: Mersive venture capital transaction
Next: 9/6/2011: Spectrum Bridge venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary